171 related articles for article (PubMed ID: 6203823)
1. Significance of mediastinal involvement in early Hodgkin's disease.
Zucali R; Zanini M; Banfi A
Hematol Oncol; 1984; 2(1):72-4. PubMed ID: 6203823
[No Abstract] [Full Text] [Related]
2. Treatment for localized Hodgkin's disease.
Crowther D
Hematol Oncol; 1984; 2(1):63-6. PubMed ID: 6203822
[No Abstract] [Full Text] [Related]
3. Combined modality (ABVD plus radiotherapy) versus radiotherapy in the management of early stage (IIA) Hodgkin's disease with mediastinal involvement.
Anselmo AP; Bove M; Cartoni C; Damico C; Maurizi Enrici R; Falchetto Osti M; Biagini C
Haematologica; 1992; 77(2):177-9. PubMed ID: 1383107
[TBL] [Abstract][Full Text] [Related]
4. Hodgkin's disease with a mediastinal mass greater than 10 cm: results of four different treatment approaches.
Preti A; Hagemeister FB; McLaughlin P; Swan F; Rodriguez A; Besa P; Cox JD; Allen PK; Cabanillas F
Ann Oncol; 1994; 5 Suppl 2():97-100. PubMed ID: 7515653
[TBL] [Abstract][Full Text] [Related]
5. Mediastinal Hodgkin's disease. Significance of mediastinal involvement in early stage Hodgkin's disease.
Mauch P; Hellman S
Hematol Oncol; 1984; 2(1):69-72. PubMed ID: 6547403
[No Abstract] [Full Text] [Related]
6. Bulky mediastinal Hodgkin's disease: results of a combined modality approach (ABVD/MOPP alternating chemotherapy plus radiation therapy).
De Lena M; Ditonno P; Lorusso V; Timurian A; Pellecchia A; Brandi M; Berardi F; Marzullo F
Haematologica; 1993; 78(4):230-5. PubMed ID: 7507457
[TBL] [Abstract][Full Text] [Related]
7. Early-stage Hodgkin's disease: long-term results with radiotherapy alone or combined radiotherapy and chemotherapy.
Brusamolino E; Lazzarino M; Orlandi E; Canevari A; Morra E; Castelli G; Alessandrino EP; Pagnucco G; Astori C; Livraghi A
Ann Oncol; 1994; 5 Suppl 2():101-6. PubMed ID: 7515642
[TBL] [Abstract][Full Text] [Related]
8. Alternating MOPP and ABVD chemotherapy plus mantle-field radiation therapy in patients with massive mediastinal Hodgkin's disease.
Longo DL; Glatstein E; Duffey PL; Young RC; Ihde DC; Bastian AW; Wilson WH; Wittes RE; Jaffe ES; Hubbard SM; DeVita VT
J Clin Oncol; 1997 Nov; 15(11):3338-46. PubMed ID: 9363863
[TBL] [Abstract][Full Text] [Related]
9. [Controversy regarding the treatment of Hodgkin's disease].
Balwierz W; Armata J
Pol Tyg Lek; 1989 Apr; 44(14):315-9. PubMed ID: 2482966
[No Abstract] [Full Text] [Related]
10. Laparotomy and splenectomy in Hodgkin's disease: a reappraisal after twenty years.
Rosenberg SA
Scand J Haematol; 1985 Apr; 34(4):289-92. PubMed ID: 2408324
[No Abstract] [Full Text] [Related]
11. The case against the routine use of radiation therapy in advanced-stage Hodgkin's disease.
Longo DL
Cancer Invest; 1996; 14(4):353-60. PubMed ID: 8689431
[No Abstract] [Full Text] [Related]
12. Radiation dose selection in Hodgkin's disease patients with large mediastinal adenopathy treated with combined modality therapy.
Elconin JH; Roberts KB; Rizzieri DA; Vermont C; Clough RW; Kim C; Dodge RK; Prosnitz LR
Int J Radiat Oncol Biol Phys; 2000 Nov; 48(4):1097-105. PubMed ID: 11072168
[TBL] [Abstract][Full Text] [Related]
13. [Advances in the chemotherapy of malignant lymphoma 1. Chemotherapy of Hodgkin's disease].
Suon SZ
Zhonghua Nei Ke Za Zhi; 1985 Feb; 24(2):117-120, contd. PubMed ID: 2580675
[No Abstract] [Full Text] [Related]
14. Randomized Phase III Trial Comparing ABVD Plus Radiotherapy With the Stanford V Regimen in Patients With Stages I or II Locally Extensive, Bulky Mediastinal Hodgkin Lymphoma: A Subset Analysis of the North American Intergroup E2496 Trial.
Advani RH; Hong F; Fisher RI; Bartlett NL; Robinson KS; Gascoyne RD; Wagner H; Stiff PJ; Cheson BD; Stewart DA; Gordon LI; Kahl BS; Friedberg JW; Blum KA; Habermann TM; Tuscano JM; Hoppe RT; Horning SJ
J Clin Oncol; 2015 Jun; 33(17):1936-42. PubMed ID: 25897153
[TBL] [Abstract][Full Text] [Related]
15. [Controversial aspects in the current treatment of Hodgkin's disease].
Vicente J
Rev Clin Esp; 1987 Feb; 180(3):158-64. PubMed ID: 2437622
[No Abstract] [Full Text] [Related]
16. Involved-field radiotherapy for patients in partial remission after chemotherapy for advanced Hodgkin's lymphoma.
Aleman BM; Raemaekers JM; Tomiŝiĉ R; Baaijens MH; Bortolus R; Lybeert ML; van der Maazen RW; Girinsky T; Demeestere G; Lugtenburg P; Lievens Y; de Jong D; Pinna A; Henry-Amar M;
Int J Radiat Oncol Biol Phys; 2007 Jan; 67(1):19-30. PubMed ID: 17097834
[TBL] [Abstract][Full Text] [Related]
17. The role of chemotherapy in the management of early stage Hodgkin's disease.
Rosenberg SA
Hematol Oncol; 1984; 2(1):61-3. PubMed ID: 6203821
[No Abstract] [Full Text] [Related]
18. Conventional salvage therapy for Hodgkin's lymphoma.
Pfreundschuh M; Schaadt M; Diehl V
Recent Results Cancer Res; 1989; 117():225-32. PubMed ID: 2481331
[No Abstract] [Full Text] [Related]
19. The cure of Hodgkin's disease with drugs.
DeVita VT; Hubbard SM; Moxley JH
Adv Intern Med; 1983; 28():277-302. PubMed ID: 6188346
[No Abstract] [Full Text] [Related]
20. ABMT recommended for relapsed Hodgkin's disease, but better overall survival not yet proved.
Oncology (Williston Park); 1996 Apr; 10(4):593-4. PubMed ID: 8723294
[No Abstract] [Full Text] [Related]
[Next] [New Search]
